AlphaQuest LLC Buys 291 Shares of Inspire Medical Systems, Inc. (NYSE:INSP)

AlphaQuest LLC boosted its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 7,275.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 295 shares of the company’s stock after purchasing an additional 291 shares during the period. AlphaQuest LLC’s holdings in Inspire Medical Systems were worth $55,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in INSP. First Horizon Advisors Inc. raised its position in Inspire Medical Systems by 885.7% in the fourth quarter. First Horizon Advisors Inc. now owns 138 shares of the company’s stock worth $26,000 after acquiring an additional 124 shares during the period. True Wealth Design LLC bought a new stake in Inspire Medical Systems in the third quarter worth about $30,000. Smartleaf Asset Management LLC increased its stake in shares of Inspire Medical Systems by 178.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 357 shares of the company’s stock worth $66,000 after purchasing an additional 229 shares in the last quarter. Nisa Investment Advisors LLC increased its stake in shares of Inspire Medical Systems by 37.3% in the fourth quarter. Nisa Investment Advisors LLC now owns 368 shares of the company’s stock worth $68,000 after purchasing an additional 100 shares in the last quarter. Finally, Quarry LP increased its stake in shares of Inspire Medical Systems by 30.9% in the third quarter. Quarry LP now owns 449 shares of the company’s stock worth $95,000 after purchasing an additional 106 shares in the last quarter. Institutional investors own 94.91% of the company’s stock.

Inspire Medical Systems Stock Performance

Shares of INSP stock opened at $163.07 on Friday. Inspire Medical Systems, Inc. has a one year low of $123.00 and a one year high of $257.40. The company’s 50-day moving average is $181.05 and its 200 day moving average is $191.43. The company has a market capitalization of $4.84 billion, a price-to-earnings ratio of 94.26, a price-to-earnings-growth ratio of 2.86 and a beta of 1.48.

Inspire Medical Systems (NYSE:INSP) last announced its quarterly earnings data on Monday, February 10th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a net margin of 6.67% and a return on equity of 8.19%. As a group, research analysts predict that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

INSP has been the subject of several recent analyst reports. Wells Fargo & Company reduced their price objective on shares of Inspire Medical Systems from $198.00 to $195.00 and set an “equal weight” rating for the company in a research note on Tuesday, February 11th. Robert W. Baird lowered their price objective on shares of Inspire Medical Systems from $252.00 to $248.00 and set an “outperform” rating for the company in a report on Tuesday, February 11th. Royal Bank of Canada reiterated an “outperform” rating and set a $260.00 price target on shares of Inspire Medical Systems in a report on Tuesday, February 11th. Stifel Nicolaus lowered their price target on shares of Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating for the company in a report on Tuesday, January 21st. Finally, KeyCorp restated an “overweight” rating and issued a $234.00 price objective (down from $236.00) on shares of Inspire Medical Systems in a report on Friday, January 24th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $228.82.

Insider Activity at Inspire Medical Systems

In other Inspire Medical Systems news, CTO John Rondoni sold 583 shares of the company’s stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $170.49, for a total transaction of $99,395.67. Following the transaction, the chief technology officer now owns 10,424 shares in the company, valued at approximately $1,777,187.76. This represents a 5.30 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Randy Ban sold 25,584 shares of the company’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $183.50, for a total transaction of $4,694,664.00. Following the transaction, the insider now owns 7,259 shares in the company, valued at $1,332,026.50. This represents a 77.90 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 26,225 shares of company stock valued at $4,806,530. 4.10% of the stock is owned by insiders.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.